Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients
Open Access
- 24 April 2007
- journal article
- research article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 10 (3) , 293-300
Abstract
Anterior gradient-2 (AGR2) expression was examined in a series of prostate cell lines and in an archival set of prostate tissues. The relative levels of AGR2 expression in the malignant cell lines PC-3 and PC-3M were, respectively, 5.3±0.1 and 3.8±0.2 times that detected in the benign cell line PNT-2. Immunohistochemical staining in 106 cases showed that amongst seven normal cases, one (14.3%) was unstained, five (71.4%) stained weakly positive and one (14.3%) stained moderately positive. Amongst 34 benign prostate hyperplastic (BPH) cases, 12 (35.3%) were unstained, 18 (52.9%) stained weakly positive and four (11.8%) stained moderately positive. Amongst 65 carcinomas, three (4.6%) were unstained, 14 (21.5%) stained weakly positive, 19 (29.2%) stained moderately positive and 29 (44.9%) stained strongly positive. AGR2 expression in carcinomas was significantly higher than that in BPH (χ2-test, PAGR2 expression was significantly (log rank test, P=0.007) associated with reduced patient-survival time. Increased joint Gleason score (GS) was significantly (log rank test, P=0.001) associated with poor patient survival. However, neither prostate specific antigen (PSA) level, nor androgen receptor (AR) index, was significantly associated with patient-survival time. Increased AGR2 expression was significantly correlated with high GS (two-sided Fisher's exact test, PU-test, P=0.047), but not significantly related to the level of AR (Mann–Whitney U-test, P=0.286). These results suggest that increased AGR2 expression is a valuable prognostic factor to predict the clinical outcome of the prostate cancer patients.Keywords
This publication has 32 references indexed in Scilit:
- Therapeutic Vaccines for Prostate CancerThe Oncologist, 2006
- Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patientsBritish Journal of Cancer, 2006
- Molecular pathology of prostate cancerJournal of Clinical Pathology, 2005
- Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast CarcinomasCancer Research, 2005
- AGR2, an androgen‐inducible secretory protein overexpressed in prostate cancerGenes, Chromosomes and Cancer, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Tazarotene-Induced Gene 1 (TIG1) Expression in Prostate Carcinomas and Its Relationship to TumorigenicityJNCI: Journal of the National Cancer Institute, 2002
- Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice 1DDBJ accession number: AB016592. 1Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- hAG-2, the Human Homologue of theXenopus laevisCement Gland Gene XAG-2, Is Coexpressed with Estrogen Receptor in Breast Cancer Cell LinesBiochemical and Biophysical Research Communications, 1998